4
Changes in Ownership
Teladoc Health, Inc. Filed Acc 0001415889-23-004109
CHIEF INNOVATION OFFICER sold 3,388 shares at $25.36 ($85,926)
- CHIEF INNOVATION OFFICER acquired 11,229 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jensen Claus Torp CHIEF INNOVATION OFFICER | 2023-03-01 | Option exercise | +11,229 | 13,011 | D: show line 1 in the form | ||
| Jensen Claus Torp CHIEF INNOVATION OFFICER | 2023-03-02 | Sale | −3,388 | $25.36 | $85,926 | 9,623 | D: show line 2 in the form |
| Open-market sales · 3,388 sh · avg $25.36 · $85,926 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jensen Claus Torp CHIEF INNOVATION OFFICER | 2023-03-01 | Option exercise · Restricted Stock Units | −11,229 | 22,459 | D: show line 3 in the form |
Loading xslF345X03/form4-03032023_090316.xml…